Acetyl Hexapeptide-8 vs Palmitoyl Tripeptide-1
A side-by-side research comparison of Acetyl Hexapeptide-8 and Palmitoyl Tripeptide-1 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Acetyl Hexapeptide-8 | Palmitoyl Tripeptide-1 |
|---|---|---|
| Full name | Acetyl Hexapeptide-8 (Argireline Advanced) | Palmitoyl Tripeptide-1 (Pal-GHK) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Same SNARE complex competition as argireline with acetyl modification for improved stability and cellular uptake. | Functions as matrikine signal, mimicking collagen fragments that trigger fibroblasts to produce new collagen. Palmitoyl enables deeper skin penetration. |
| Molecular weight | 889 Da | 578.8 Da |
| Half-life | 10-14 hours | 8-12 hours (topical) |
| Bioavailability | Improved (topical, acetylated) | Good (topical with lipid modification) |
| Typical dose | 5-10% | 2-5% in formulation |
| Frequency | 2x daily | 1-2x daily |
| Route | Topical | Topical |
Acetyl Hexapeptide-8 reported benefits
- Improved stability
- Expression wrinkle reduction
- Preventative anti-aging
- Compatible with most formulations
Palmitoyl Tripeptide-1 reported benefits
- Collagen synthesis stimulation
- Matrix remodeling
- Wrinkle reduction
- Skin thickness increase
Related comparisons
Research and educational reference only. Not medical advice.